Turkey
Viseur AI, founded in 2024 and headquartered in Turkey, is a pioneering digital pathology platform that aims to revolutionize the field of medical diagnostics. With the slogan, "Better disease diagnosis for everyone!", the company is on a mission to streamline the fragmented and often inefficient workflows in pathology labs through its comprehensive, vendor-agnostic solution.
The platform integrates Pathology Information Management (PIMS), digital pathology viewing, AI model deployment, and governance into a unified system, enhancing standardization and scalability across healthcare networks. By addressing limitations in existing scanner-locked software and infrequent AI deployment, Viseur AI enables end-to-end solutions that support clinical workflows from specimen handling to reporting. The company is compliant with critical industry standards such as ISO 13485, ISO 27001, and ISO/IEC 15504-SPICE, reflecting its commitment to quality and security.
Currently operating in the AI, Healthcare, and Life Sciences sectors, Viseur AI secured a €300.00K early VC investment from APY Ventures in May 2026, indicating strong investor confidence in its innovative approach and market potential.
